Iloprost for prevention of contrast-mediated nephropathy in high-risk patients undergoing a coronary procedure. Results of a randomized pilot study

Author: Spargias K.   Adreanides E.   Giamouzis G.   Karagiannis S.   Gouziouta A.   Manginas A.   Voudris V.   Pavlides G.   Cokkinos D.  

Publisher: Springer Publishing Company

ISSN: 0031-6970

Source: European Journal of Clinical Pharmacology, Vol.62, Iss.8, 2006-08, pp. : 589-595

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content